+499.5%
MRNA vs NIO
-37.4%
+536.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.6% | -0.7% | -1.9% |
| 7D | +5.5% | -13.0% | +18.5% | +8.9% |
| 30D | +158.7% | -18.3% | +177.0% | +171.4% |
| 3M | +182.1% | -33.2% | +215.3% | +202.9% |
| 6M | +151.8% | -21.5% | +173.3% | +162.7% |
| YTD | +393.6% | -25.5% | +419.0% | +415.9% |
| 1Y | +499.5% | -38.0% | +537.5% | +550.8% |
| All | +499.5% | -37.4% | +536.9% | +550.8% |
Cumulative growth
Daily Returns
Daily percentage return beside NIO.
Daily Out/Under-Performance
Portfolio return minus NIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling